Successful Treatment of Primary Cardiac Lymphoma With Monoclonal CD20 Antibody (Rituximab)
Primary cardiac malignant lymphoma is extremely rare and almost all patients die within weeks. Monoclonal CD20 antibody (rituximab) was administered to a patient with primary cardiac B-cell non-Hodgkin's lymphoma expressing a CD20 molecule. The results suggest that rituximab may be a safe and e...
Gespeichert in:
| Veröffentlicht in: | Circulation Journal 2004, Vol.68(2), pp.172-173 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 173 |
|---|---|
| container_issue | 2 |
| container_start_page | 172 |
| container_title | Circulation Journal |
| container_volume | 68 |
| creator | Nakagawa, Yukinori Ikeda, Uichi Hirose, Masahiro Ubukata, Satoshi Katsuki, Taka-aki Kaminishi, Yuichiro Saito, Tsutomu Hironaka, Mitsugu Izumi, Tohru Shimada, Kazuyuki |
| description | Primary cardiac malignant lymphoma is extremely rare and almost all patients die within weeks. Monoclonal CD20 antibody (rituximab) was administered to a patient with primary cardiac B-cell non-Hodgkin's lymphoma expressing a CD20 molecule. The results suggest that rituximab may be a safe and effective new therapy for primary cardiac B-cell lymphoma. (Circ J 2004; 68: 172 - 173) |
| doi_str_mv | 10.1253/circj.68.172 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80118316</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80118316</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-b1ce4e91f57e1818c258099c1110a2a00a2003281bf8dcdd22e2d89e8c4d0e9a3</originalsourceid><addsrcrecordid>eNpFkE1Lw0AQhhdRbK3ePMueRMHUnU3SbI6lfkJF8QPBy7LZTGxKkq27G7D_3miKvcwMzDMvzEPIMbAx8Di81KXVy_FEjCHhO2QIYZQEkeBs92-eBKmIwgE5cG7JGE9ZnO6TAURJFEMcD8nHS6s1Ole0FX21qHyNjaemoE-2rJVd05myeak0na_r1cLUir6XfkEfTGN0ZRpV0dkVZ3Ta-DIz-ZqePZe-_e5Os_NDsleoyuHRpo_I28316-wumD_e3s-m80BHSeyDDDRGmEIRJwgChOaxYGmqAYAprlhXGAu5gKwQuc5zzpHnIkWho5xhqsIROe1zV9Z8tei8rEunsapUg6Z1UjAAEcKkAy96UFvjnMVCrvonJTD561L-uZQTITuXHX6yyW2zGvMtvJHXAdMeWDqvPvEfUNaXusJtGu9LF7rdLZSV2IQ_8sSHmg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80118316</pqid></control><display><type>article</type><title>Successful Treatment of Primary Cardiac Lymphoma With Monoclonal CD20 Antibody (Rituximab)</title><source>MEDLINE</source><source>J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Nakagawa, Yukinori ; Ikeda, Uichi ; Hirose, Masahiro ; Ubukata, Satoshi ; Katsuki, Taka-aki ; Kaminishi, Yuichiro ; Saito, Tsutomu ; Hironaka, Mitsugu ; Izumi, Tohru ; Shimada, Kazuyuki</creator><creatorcontrib>Nakagawa, Yukinori ; Ikeda, Uichi ; Hirose, Masahiro ; Ubukata, Satoshi ; Katsuki, Taka-aki ; Kaminishi, Yuichiro ; Saito, Tsutomu ; Hironaka, Mitsugu ; Izumi, Tohru ; Shimada, Kazuyuki</creatorcontrib><description>Primary cardiac malignant lymphoma is extremely rare and almost all patients die within weeks. Monoclonal CD20 antibody (rituximab) was administered to a patient with primary cardiac B-cell non-Hodgkin's lymphoma expressing a CD20 molecule. The results suggest that rituximab may be a safe and effective new therapy for primary cardiac B-cell lymphoma. (Circ J 2004; 68: 172 - 173)</description><identifier>ISSN: 1346-9843</identifier><identifier>EISSN: 1347-4820</identifier><identifier>DOI: 10.1253/circj.68.172</identifier><identifier>PMID: 14745155</identifier><language>eng</language><publisher>Japan: The Japanese Circulation Society</publisher><subject>Adult ; Antibodies, Monoclonal - therapeutic use ; Antibodies, Monoclonal, Murine-Derived ; Antibody ; B cells ; Cardiac tumor ; Gallium Radioisotopes ; Heart Neoplasms - diagnosis ; Heart Neoplasms - drug therapy ; Humans ; Immunohistochemistry ; Lymphoma ; Lymphoma, B-Cell - diagnosis ; Lymphoma, B-Cell - drug therapy ; Male ; Radionuclide Imaging ; Remission Induction - methods ; Rituximab ; Tomography, X-Ray Computed</subject><ispartof>Circulation Journal, 2004, Vol.68(2), pp.172-173</ispartof><rights>2004 THE JAPANESE CIRCULATION SOCIETY</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-b1ce4e91f57e1818c258099c1110a2a00a2003281bf8dcdd22e2d89e8c4d0e9a3</citedby><cites>FETCH-LOGICAL-c475t-b1ce4e91f57e1818c258099c1110a2a00a2003281bf8dcdd22e2d89e8c4d0e9a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1883,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14745155$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nakagawa, Yukinori</creatorcontrib><creatorcontrib>Ikeda, Uichi</creatorcontrib><creatorcontrib>Hirose, Masahiro</creatorcontrib><creatorcontrib>Ubukata, Satoshi</creatorcontrib><creatorcontrib>Katsuki, Taka-aki</creatorcontrib><creatorcontrib>Kaminishi, Yuichiro</creatorcontrib><creatorcontrib>Saito, Tsutomu</creatorcontrib><creatorcontrib>Hironaka, Mitsugu</creatorcontrib><creatorcontrib>Izumi, Tohru</creatorcontrib><creatorcontrib>Shimada, Kazuyuki</creatorcontrib><title>Successful Treatment of Primary Cardiac Lymphoma With Monoclonal CD20 Antibody (Rituximab)</title><title>Circulation Journal</title><addtitle>Circ J</addtitle><description>Primary cardiac malignant lymphoma is extremely rare and almost all patients die within weeks. Monoclonal CD20 antibody (rituximab) was administered to a patient with primary cardiac B-cell non-Hodgkin's lymphoma expressing a CD20 molecule. The results suggest that rituximab may be a safe and effective new therapy for primary cardiac B-cell lymphoma. (Circ J 2004; 68: 172 - 173)</description><subject>Adult</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antibodies, Monoclonal, Murine-Derived</subject><subject>Antibody</subject><subject>B cells</subject><subject>Cardiac tumor</subject><subject>Gallium Radioisotopes</subject><subject>Heart Neoplasms - diagnosis</subject><subject>Heart Neoplasms - drug therapy</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Lymphoma</subject><subject>Lymphoma, B-Cell - diagnosis</subject><subject>Lymphoma, B-Cell - drug therapy</subject><subject>Male</subject><subject>Radionuclide Imaging</subject><subject>Remission Induction - methods</subject><subject>Rituximab</subject><subject>Tomography, X-Ray Computed</subject><issn>1346-9843</issn><issn>1347-4820</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1Lw0AQhhdRbK3ePMueRMHUnU3SbI6lfkJF8QPBy7LZTGxKkq27G7D_3miKvcwMzDMvzEPIMbAx8Di81KXVy_FEjCHhO2QIYZQEkeBs92-eBKmIwgE5cG7JGE9ZnO6TAURJFEMcD8nHS6s1Ole0FX21qHyNjaemoE-2rJVd05myeak0na_r1cLUir6XfkEfTGN0ZRpV0dkVZ3Ta-DIz-ZqePZe-_e5Os_NDsleoyuHRpo_I28316-wumD_e3s-m80BHSeyDDDRGmEIRJwgChOaxYGmqAYAprlhXGAu5gKwQuc5zzpHnIkWho5xhqsIROe1zV9Z8tei8rEunsapUg6Z1UjAAEcKkAy96UFvjnMVCrvonJTD561L-uZQTITuXHX6yyW2zGvMtvJHXAdMeWDqvPvEfUNaXusJtGu9LF7rdLZSV2IQ_8sSHmg</recordid><startdate>20040201</startdate><enddate>20040201</enddate><creator>Nakagawa, Yukinori</creator><creator>Ikeda, Uichi</creator><creator>Hirose, Masahiro</creator><creator>Ubukata, Satoshi</creator><creator>Katsuki, Taka-aki</creator><creator>Kaminishi, Yuichiro</creator><creator>Saito, Tsutomu</creator><creator>Hironaka, Mitsugu</creator><creator>Izumi, Tohru</creator><creator>Shimada, Kazuyuki</creator><general>The Japanese Circulation Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040201</creationdate><title>Successful Treatment of Primary Cardiac Lymphoma With Monoclonal CD20 Antibody (Rituximab)</title><author>Nakagawa, Yukinori ; Ikeda, Uichi ; Hirose, Masahiro ; Ubukata, Satoshi ; Katsuki, Taka-aki ; Kaminishi, Yuichiro ; Saito, Tsutomu ; Hironaka, Mitsugu ; Izumi, Tohru ; Shimada, Kazuyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-b1ce4e91f57e1818c258099c1110a2a00a2003281bf8dcdd22e2d89e8c4d0e9a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antibodies, Monoclonal, Murine-Derived</topic><topic>Antibody</topic><topic>B cells</topic><topic>Cardiac tumor</topic><topic>Gallium Radioisotopes</topic><topic>Heart Neoplasms - diagnosis</topic><topic>Heart Neoplasms - drug therapy</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Lymphoma</topic><topic>Lymphoma, B-Cell - diagnosis</topic><topic>Lymphoma, B-Cell - drug therapy</topic><topic>Male</topic><topic>Radionuclide Imaging</topic><topic>Remission Induction - methods</topic><topic>Rituximab</topic><topic>Tomography, X-Ray Computed</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nakagawa, Yukinori</creatorcontrib><creatorcontrib>Ikeda, Uichi</creatorcontrib><creatorcontrib>Hirose, Masahiro</creatorcontrib><creatorcontrib>Ubukata, Satoshi</creatorcontrib><creatorcontrib>Katsuki, Taka-aki</creatorcontrib><creatorcontrib>Kaminishi, Yuichiro</creatorcontrib><creatorcontrib>Saito, Tsutomu</creatorcontrib><creatorcontrib>Hironaka, Mitsugu</creatorcontrib><creatorcontrib>Izumi, Tohru</creatorcontrib><creatorcontrib>Shimada, Kazuyuki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nakagawa, Yukinori</au><au>Ikeda, Uichi</au><au>Hirose, Masahiro</au><au>Ubukata, Satoshi</au><au>Katsuki, Taka-aki</au><au>Kaminishi, Yuichiro</au><au>Saito, Tsutomu</au><au>Hironaka, Mitsugu</au><au>Izumi, Tohru</au><au>Shimada, Kazuyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Successful Treatment of Primary Cardiac Lymphoma With Monoclonal CD20 Antibody (Rituximab)</atitle><jtitle>Circulation Journal</jtitle><addtitle>Circ J</addtitle><date>2004-02-01</date><risdate>2004</risdate><volume>68</volume><issue>2</issue><spage>172</spage><epage>173</epage><pages>172-173</pages><issn>1346-9843</issn><eissn>1347-4820</eissn><abstract>Primary cardiac malignant lymphoma is extremely rare and almost all patients die within weeks. Monoclonal CD20 antibody (rituximab) was administered to a patient with primary cardiac B-cell non-Hodgkin's lymphoma expressing a CD20 molecule. The results suggest that rituximab may be a safe and effective new therapy for primary cardiac B-cell lymphoma. (Circ J 2004; 68: 172 - 173)</abstract><cop>Japan</cop><pub>The Japanese Circulation Society</pub><pmid>14745155</pmid><doi>10.1253/circj.68.172</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1346-9843 |
| ispartof | Circulation Journal, 2004, Vol.68(2), pp.172-173 |
| issn | 1346-9843 1347-4820 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_80118316 |
| source | MEDLINE; J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese; EZB-FREE-00999 freely available EZB journals |
| subjects | Adult Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Murine-Derived Antibody B cells Cardiac tumor Gallium Radioisotopes Heart Neoplasms - diagnosis Heart Neoplasms - drug therapy Humans Immunohistochemistry Lymphoma Lymphoma, B-Cell - diagnosis Lymphoma, B-Cell - drug therapy Male Radionuclide Imaging Remission Induction - methods Rituximab Tomography, X-Ray Computed |
| title | Successful Treatment of Primary Cardiac Lymphoma With Monoclonal CD20 Antibody (Rituximab) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T04%3A26%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Successful%20Treatment%20of%20Primary%20Cardiac%20Lymphoma%20With%20Monoclonal%20CD20%20Antibody%20(Rituximab)&rft.jtitle=Circulation%20Journal&rft.au=Nakagawa,%20Yukinori&rft.date=2004-02-01&rft.volume=68&rft.issue=2&rft.spage=172&rft.epage=173&rft.pages=172-173&rft.issn=1346-9843&rft.eissn=1347-4820&rft_id=info:doi/10.1253/circj.68.172&rft_dat=%3Cproquest_cross%3E80118316%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80118316&rft_id=info:pmid/14745155&rfr_iscdi=true |